Adult Pulmonary Vascular Disease

Usefulness of cutting balloon angioplasty for pulmonary vein in-stent stenosis

Amanda L. Cook, Lourdes R. Prieto, Jeffrey W. Delaney, John F. RhodesDuke University Medical Center.United States American Journal of CardiologyAm J Cardiol 2006; 98: 407-410DOI: 10.1016/j.amjcard.2006.02.049 AbstractAfter radiofrequency ablation for atrial fibrillation, patients may develop pulmonary vein stenoses requiring stent angioplasty. The treatment options for when such patients develop in-stent stenoses are poorly defined. The investigators […]

Usefulness of cutting balloon angioplasty for pulmonary vein in-stent stenosis Read More »

Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial Hypertension

Franz P. Rischard, Roberto J. Bernardo, Rebecca R. Vanderpool, Deborah H. Kwon, Tuschar Acharya, Margaret M. Park, Austin Katrynuik, Michael Insel, Saad Kubba, Roberto Badagliacca, A. Brett Larive, Robert Naeije, Joe G. N. Garcia, Gerald J. Beck, Serpil C. Erzurum, Robert P. Frantz, Paul M. Hassoun, Anna R. Hemnes, Nicholas S. Hill, Evelyn M. Horn,

Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial Hypertension Read More »

Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute’s Innovative Drug Development Initiative – Group 3 Pulmonary Hypertension

Lucilla Piccari, Brian Allwood, Katerina Antoniou, Jonathan H. Chung, Paul M. Hassoun, Sylvia M. Nikkho, Rajan Saggar, Oksana A. Shlobin, Patrizio Vitulo, Steven D. Nathan, Stephen John WortHospital del Mar. Stellenbosch University and Tygerberg Hospital. University of Crete School of Medicine. The University of Chicago. Johns Hopkins University. Bayer AG. University of California Los Angeles

Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute’s Innovative Drug Development Initiative – Group 3 Pulmonary Hypertension Read More »

NT-proBNP Is a Predictor of Mortality in Adults with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease

Susanne J. Maurer, Veronika Habdank, Jürgen Hörer, Peter Ewert, Oktay TutarelGerman Heart Centre Munich and Technical University of Munich. Ludwig-Maximilians Universität.Germany Journal of Clinical MedicineJ Clin Med 2023; 12DOI: 10.3390/jcm12093101 AbstractBackground: About 5-10% of adults with congenital heart disease (ACHD) will develop pulmonary arterial hypertension (PAH), which is associated with significant mortality. Studies on risk factors for

NT-proBNP Is a Predictor of Mortality in Adults with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease Read More »

Fatal Association of Eisenmenger Syndrome and Severe Preeclampsia

Said Benlamkaddem, Fatima Bouyermane, Djoudline Doughmi, Mohamed Adnane Berdai, Mustapha HarandouHassan II University Hospital. Sidi Mohamed Ben Abdellah University. Morocco CureusCureus 2023; 15DOI: 10.7759/cureus.37836 AbstractEisenmenger syndrome (ES) is the end stage of pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD), which can occur in patients with large, unrepaired cardiac shunts (ventricular septal defects (VSD),

Fatal Association of Eisenmenger Syndrome and Severe Preeclampsia Read More »

Frequency of acute vasodilator response (AVR) in incident and prevalent patients with pulmonary arterial hypertension: Results from the pulmonary vascular disease phenomics study

Mario Naranjo, Erika B. Rosenzweig, Anna B. Hemnes, Miriam Jacob, Ankit Desai, Nicholas S. Hill, A. Brett Larive, J. Emanuel Finet, Jane Leopold, Evelyn Horn, Robert Frantz, Frans Rischard, Serpil Erzurum, Gerald Beck, Stephen C. Mathai, Paul M. HassounJohns Hopkins University. Columbia University. Vanderbilt University Medical Center. Cleveland Clinic. University of Arizona College of Medicine.

Frequency of acute vasodilator response (AVR) in incident and prevalent patients with pulmonary arterial hypertension: Results from the pulmonary vascular disease phenomics study Read More »

Metabolomic differences in connective tissue disease-associated versus idiopathic pulmonary arterial hypertension in the PVDOMICS cohort

Catherine E. Simpson, Anna R. Hemnes, Megan Griffiths, Gabriele Grunig, W. H. Wison Tang, Joe G. N. Garcia, John Barnard, Suzy A. Comhair, Rachel L. Damico, Stephen C. Mathai, Paul M. Hassoun, the PVDOMICS Study GroupJohns Hopkins University. Vanderbilt University. University of Texas Southwestern Medical Center. New York University Grossman School of Medicine. Cleveland Clinic.

Metabolomic differences in connective tissue disease-associated versus idiopathic pulmonary arterial hypertension in the PVDOMICS cohort Read More »

Atrial septal defect-associated pulmonary hypertension with decompensated heart failure: outcomes after fenestrated device closure

Ahmad Deniwar, Jason Hernandez, Enrique O. Aregullin, Sana K. Khan, Sihong Huang, Michael T. Finn, Joseph J. VettukattilHelen DeVos Children’s Hospital of Spectrum Health Hospital and Michigan State University College of Human Medicine.United States Cardiology in the YoungCardiol Young 2023; DOI: 10.1017/S104795112300152X AbstractBackground: Up to 90% of adults with untreated atrial septal defect will be symptomatic by

Atrial septal defect-associated pulmonary hypertension with decompensated heart failure: outcomes after fenestrated device closure Read More »

The results of atrial flow regulator implantation in pulmonary arterial hypertension patients with severe heart failure despite maximal medical therapy

Grzegorz Kopeć, Aleksander Araszkiewicz, Wojciech Magoń, Jakub Stępniewski, Sylwia Sławek-Szmyt, Magdalena Janus, Ilona Skoczylas, Zbigniew Gąsior, Łukasz Wilczek, Monika Komar, Andrzej Gackowski, Anna Sabiniewicz, Marek Grygier, Piotr Podolec, Robert SabiniewiczJagiellonian University Medical College and John Paul II Hospital in Krakow. University of Medical Sciences. Medical University of Silesia. Medical University of Gdansk.Poland Kardiologia PolskaKardiol Pol

The results of atrial flow regulator implantation in pulmonary arterial hypertension patients with severe heart failure despite maximal medical therapy Read More »

Single-Cell Analysis Reveals Distinct Immune and Smooth Muscle Cell Populations that Contribute to Chronic Thromboembolic Pulmonary Hypertension

Gayathri Viswananthan, Helene Fradin Kirshner, Nour Nazo, Saba Ali, Asvin Ganapathi, Ian Cumming, Youghua Zhuang, Issac Choi, Anmol Warman, Chanpreet Jassal, Susana Almeida-Peters, John Haney, David Corcoran, Yen-Rei Yu, Sudarshan RajagopalUniversity of Colorado Anschutz Medical Campus. Duke University School of Medicine.United States American Journal of Respiratory and Critical Care MedicineAm J Respir Crit Care Med

Single-Cell Analysis Reveals Distinct Immune and Smooth Muscle Cell Populations that Contribute to Chronic Thromboembolic Pulmonary Hypertension Read More »

Scroll to Top